Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) went up by 7.45% from its latest closing price when compared to the 1-year high value of $12.02 and move down -85.21%, while MDRX stocks collected +18.00% of gains with the last five trading sessions. Press Release reported on 03/18/20 that Allscripts response to the COVID-19 outbreak

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Worth an Investment?

Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) The 36 Months beta value for MDRX stocks is at 1.41, while of the analysts out of 0 who provided ratings for Allscripts Healthcare Solutions, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $9.97 which is $3.54 above current price. MDRX currently has a short float of 17.11% and public float of 160.33M with average trading volume of 2.45M shares.

MDRX Market Performance

MDRX stocks went up by 18.00% for the week, with the monthly drop of -20.95% and a quarterly performance of -34.04%, while its annual performance rate touched -33.98%. The simple moving average for the period of the last 20 days is -0.96% for MDRX stocks with the simple moving average of -33.85% for the last 200 days.

Analysts’ Opinion on Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

Many brokerage firms have already submitted their reports for MDRX stocks, with UBS repeating the rating for MDRX shares by setting it to “Neutral”. The predicted price for MDRX socks in the upcoming period according to UBS is $11.50 based on the research report published on November 26, 2019.

Deutsche Bank, on the other hand, stated in their research note that they expect to see MDRX stock at the price of $11. The rating they have provided for MDRX stocks is “Hold” according to the report published on September 26, 2019.

KeyBanc Capital Markets gave “ Sector Weight” rating to MDRX stocks, setting the target price at $11 in the report published on February 22, 2019.

MDRX Stocks -19.22% Far from 50 Day Moving Average

After a stumble in the market that brought MDRX to its low price for the period of the last 52 weeks, Allscripts Healthcare Solutions, Inc. was unable to take a rebound, for now settling with -46.01% of loss for the given period.

The stock volatility was left at 10.97%, however, within the period of a single month, the volatility rate increased by 14.27%, while the shares sank at the distance of -20.76% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -31.76% lower at the present time.

In the course of the last 5 trading sessions, MDRX went up by +18.00%, which changed the moving average for the period of 200 days to the total of -37.48% of losses for the stock in comparison to the 20-day moving average settled at $6.47. In addition, Allscripts Healthcare Solutions, Inc. saw -33.88% in overturn over the period of a single year with a tendency to cut further losses.

MDRX Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Allscripts Healthcare Solutions, Inc. (MDRX), starting from Poulton Richard J., who bought 15,000 shares at the price of $7.40 back on Mar 05. After this action, Rushing now owns 660,998 shares of Allscripts Healthcare Solutions, Inc., valued at $111,000 with the latest closing price.

Black Paul, the CEO of Allscripts Healthcare Solutions, Inc., bought 33,783 shares at the value of $7.47 during a trade that took place back on Mar 05, which means that Black Paul is holding 1,756,462 shares at the value of $252,190 based on the most recent closing price.

MDRX Stock Fundamentals

The current profitability levels are settled at +0.48 for the present operating margin and +38.73 for gross margin. The net margin for Allscripts Healthcare Solutions, Inc. stands at -10.28. Equity return holds the value -13.60%, with -5.60% for asset returns.